The Deep Brain Stimulation (DBS) Devices Market size was estimated USD 1.29 billion in 2023 and is expected to reach USD 2.78 billion By 2031 at a CAGR of 10% during the forecast period of 2024-2031.
Parkinson's Disease (PD) is a neurological condition that affects multiple systems and presents a variety of symptoms. It is the second most common age-related neurodegenerative disease in the world. In 2022, over 90,000 people in the U.S. were diagnosed with Parkinson's disease, which is a 50% increase from the previously anticipated rate of 60,000 diagnoses per year. Deep Brain Stimulation (DBS) is a popular treatment method for diseases like Parkinson's disease and epilepsy. DBS is effective in controlling symptoms while minimizing side effects, unlike pharmaceutical drugs, which lose efficacy over time and require higher doses, resulting in new side effects. DBS's effectiveness in reducing pharmaceutical dosages is a significant factor driving the industry's revenue growth.
-Devices-Market2(1).png)
Experts predict that the market will experience a rise in revenue as a result of the creation of new DBS systems. In order to improve safety and effectiveness, there is an increase in innovation, research, and development of DBS systems. Traditional DBS devices can only send electrical impulses at one frequency to one location, leading to negative effects. Directional DBS, however, has the ability to manipulate the electric current both vertically and horizontally, enabling medical professionals to stimulate only the brain regions associated with the patient's symptoms. The market's revenue growth is driven by the increasing acceptance of Directional DBS systems by government organisations. An example of this is the approval of the Boston Scientific Vercise device by the U.S. Food and Drug Administration (FDA) for treating Parkinson's disease-related tremors. This system utilises an implantable pulse generator (IPG) with multiple power sources and directed DBS. Unlike traditional DBS devices, the Vercise device has multiple leads that send electrical signals, allowing for greater flexibility and accuracy in therapy by adjusting the size and design of the brain stimulation.
DRIVERS
The prevalence of neurological disorders is on the rise, as is technological progress. Additionally, there is a growing number of seniors in the population. Furthermore, less invasive medical procedures are becoming increasingly popular.
RESTRAIN
The high costs of treatment and potential side effects are major concerns, as well as the low level of accessibility and knowledge surrounding the issue.
In certain regions with limited healthcare resources, some patients may be unable to receive DBS therapy due to the high expense of DBS devices and associated procedures. Furthermore, insufficient awareness and understanding of DBS treatment among patients and healthcare professionals in certain areas may lead to underutilization of these devices.
OPPORTUNITY
Research and Development of Emerging Technologies in Untapped Markets.
CHALLENGES
Obstacles in Regulation, Competition for Alternative Therapies, and Ethical Issues.
Clearing medical devices for use, particularly DBS devices, can be a rigorous process that may cause delays in introducing new products. DBS devices face competition from alternative therapies like medication and other neuromodulation techniques. When DBS devices are employed to treat certain neurological or psychiatric conditions, ethical concerns about patient selection and treatment standards arise.
The ongoing conflict between Russia and Ukraine is putting a lot of strain on their healthcare infrastructure. Hospitals and medical facilities are struggling to provide deep brain stimulation (DBS) procedures due to the diversion of resources to handle crises and specialized treatments related to the conflict. Additionally, governments may prioritize resources and establish regulations that may affect the medical device sector, particularly DBS devices, during times of conflict. Import and export regulations, approval of medical devices, and healthcare practices may all undergo changes. Ongoing conflicts may also divert funds and attention from research and development initiatives, slowing down the progress of cutting-edge DBS devices and systems in both nations.
The geopolitical tensions caused by the ongoing war may result in unpredictable regional markets. This could affect investment decisions and hinder the growth and development of medical device businesses in the affected areas, particularly those that specialize in DBS devices. As a result of the disruptions in healthcare services and facilities, patients in the impacted locations may also experience difficulties accessing DBS treatments.
IMPACT OF ONGOING RECESSION
During a recession, healthcare professionals may prioritize urgent care and vital medical needs over elective procedures like DBS therapy. The economic downturn can also impact the production, distribution, and availability of DBS devices and other medical equipment due to supply chain breakdowns. Smaller medical device firms may face difficulties, leading to market consolidation as larger businesses buy or combine with them, potentially affecting market dynamics and competitiveness. Additionally, governments and insurers may review reimbursement policies for medical equipment during a recession, which could impact the rates for DBS operations.
By Product
Single Channel
Dual Channel
By Application
Pain Management
Epilepsy
Essential Tremor
Obsessive-Compulsive Disorder (OCD)
Depression
Dystonia
Parkinson’s Disease
Others
By End Use
Hospitals
Neurology Clinics
Ambulatory Surgical Centres
Research Centres
-Devices-Market(1).png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
North America is currently leading the market for Parkinson's disease (PD) due to increased government spending and public awareness campaigns. This trend is expected to continue as the demand for deep brain stimulators rises. The FDA's increasing approval of deep brain stimulators for the treatment of PD is also contributing to the expansion of the market. Moreover, the presence of strong competitors, advanced healthcare infrastructure, and supportive government initiatives are all contributing to the growth of this industry.
Between 2024 and 2031, the Asia-Pacific region is expected to dominate the market due to an increase in the frequency of neurodegenerative diseases and the need for practical, long-lasting remedies. This area's market is predicted to grow due to better clinical development frameworks in emerging economies and increasing knowledge of available treatments for neurological diseases. Furthermore, the high growth potential in developing countries such as Japan, China, and India likely to support market expansion. Additionally, the establishment of institutions such as the Asia-Pacific Centre for Neuromodulation (APCN), which is conducting research and raising awareness about the benefits of deep brain stimulation, should drive regional growth.
The major key players are, Nevro Corporation, Abbott Laboratories, Neuronetics Inc., Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd., LivaNova PLC and others.
Aster Medcity: In 18 August 2022, Aster Medcity, in partnership with India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, is working together to develop a comprehensive and cutting-edge Deep Brain Stimulation (DBS) programme for Parkinson's patients in India. This collaboration involves Aster's teams providing medical and surgical expertise in DBS therapy to support the Aster Centre for Parkinson's and Movement Disorders, alongside Medtronic's portfolio of DBS equipment, technical knowledge, and support. It is our pleasure to announce that Aster Medcity Kochi has become the first facility in South Asia to use the NeuroNav MER system (Alpha Omega), the latest version of the Microelectrode recording system for DBS treatments from Medtronic.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.29 Bn |
| Market Size by 2031 | US$ 2.78 Bn |
| CAGR | CAGR of 9.9 % From 2023 to 2030 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Single Channel, Dual Channel) • By Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Others) • By End Use (Hospitals, Neurology Clinics, Ambulatory Surgical Centres, Research Centres) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Nevro Corporation, Abbott Laboratories, Neuronetics Inc., Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd., LivaNova PLC |
| Key Drivers | • The prevalence of neurological disorders is on the rise, as is technological progress. Additionally, there is a growing number of seniors in the population. Furthermore, less invasive medical procedures are becoming increasingly popular. |
| Market Restraints | • The high costs of treatment and potential side effects are major concerns, as well as the low level of accessibility and knowledge surrounding the issue. |
Ans: The Deep Brain Stimulation (DBS) Devices Market is expected to grow at 10% CAGR from 2024 to 2031.
Ans: The Deep Brain Stimulation (DBS) Devices Market is anticipated to reach USD 2.78 billion by 2031.
Ans: The prevalence of neurological illnesses is rising, people want a tailored approach, and technical improvements are major growth drivers for the deep brain stimulation device market.
Ans: The leading participants in the, Nevro Corporation, Abbott Laboratories, Neuronetics Inc., Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Deep Brain Stimulation (DBS) Devices Market, By Product
8.1 Single Channel
8.2 Dual Channel
9. Deep Brain Stimulation (DBS) Devices Market, By Application
9.1 Pain Management
9.2 Epilepsy
9.3 Essential Tremor
9.4 Obsessive-Compulsive Disorder (OCD)
9.5 Depression
9.6 Dystonia
9.7 Parkinson’s Disease
9.8 Others
10. Deep Brain Stimulation (DBS) Devices Market, By End Use
10.1 Hospitals
10.2 Neurology Clinics
10.3 Ambulatory Surgical Centres
10.4 Research Centres
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Deep Brain Stimulation (DBS) Devices Market by country
11.2.2North America Deep Brain Stimulation (DBS) Devices Market by Product
11.2.3 North America Deep Brain Stimulation (DBS) Devices Market by Application
11.2.4 North America Deep Brain Stimulation (DBS) Devices Market by End-Use Channel
11.2.5 USA
11.2.5.1 USA Deep Brain Stimulation (DBS) Devices Market by Product
11.2.5.2 USA Deep Brain Stimulation (DBS) Devices Market by Application
11.2.5.3 USA Deep Brain Stimulation (DBS) Devices Market by End-Use
11.2.6 Canada
11.2.6.1 Canada Deep Brain Stimulation (DBS) Devices Market by Product
11.2.6.2 Canada Deep Brain Stimulation (DBS) Devices Market by Application
11.2.6.3 Canada Deep Brain Stimulation (DBS) Devices Market by End-Use
11.2.7 Mexico
11.2.7.1 Mexico Deep Brain Stimulation (DBS) Devices Market by Product
11.2.7.2 Mexico Deep Brain Stimulation (DBS) Devices Market by Application
11.2.7.3 Mexico Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Deep Brain Stimulation (DBS) Devices Market by country
11.3.1.2 Eastern Europe Deep Brain Stimulation (DBS) Devices Market by Product
11.3.1.3 Eastern Europe Deep Brain Stimulation (DBS) Devices Market by Application
11.3.1.4 Eastern Europe Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.1.5 Poland
11.3.1.5.1 Poland Deep Brain Stimulation (DBS) Devices Market by Product
11.3.1.5.2 Poland Deep Brain Stimulation (DBS) Devices Market by Application
11.3.1.5.3 Poland Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.1.6 Romania
11.3.1.6.1 Romania Deep Brain Stimulation (DBS) Devices Market by Product
11.3.1.6.2 Romania Deep Brain Stimulation (DBS) Devices Market by Application
11.3.1.6.4 Romania Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.1.7 Turkey
11.3.1.7.1 Turkey Deep Brain Stimulation (DBS) Devices Market by Product
11.3.1.7.2 Turkey Deep Brain Stimulation (DBS) Devices Market by Application
11.3.1.7.3 Turkey Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Deep Brain Stimulation (DBS) Devices Market by Product
11.3.1.8.2 Rest of Eastern Europe Deep Brain Stimulation (DBS) Devices Market by Application
11.3.1.8.3 Rest of Eastern Europe Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2 Western Europe
11.3.2.1 Western Europe Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.2 Western Europe Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.3 Western Europe Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.4 Germany
11.3.2.4.1 Germany Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.4.2 Germany Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.4.3 Germany Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.5 France
11.3.2.5.1 France Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.5.2 France Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.5.3 France Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.6 UK
11.3.2.6.1 UK Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.6.2 UK Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.6.3 UK Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.7 Italy
11.3.2.7.1 Italy Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.7.2 Italy Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.7.3 Italy Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.8 Spain
11.3.2.8.1 Spain Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.8.2 Spain Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.8.3 Spain Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.9.2 Netherlands Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.9.3 Netherlands Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.10.2 Switzerland Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.10.3 Switzerland Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.11.1 Austria
11.3.2.11.2 Austria Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.11.3 Austria Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.11.4 Austria Deep Brain Stimulation (DBS) Devices Market by End-Use
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Deep Brain Stimulation (DBS) Devices Market by Product
11.3.2.12.2 Rest of Western Europe Deep Brain Stimulation (DBS) Devices Market by Application
11.3.2.12.3 Rest of Western Europe Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4 Asia-Pacific
11.4.1 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by country
11.4.2 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by Product
11.4.3 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by Application
11.4.4 Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.5 China
11.4.5.1 China Deep Brain Stimulation (DBS) Devices Market by Product
11.4.5.2 China Deep Brain Stimulation (DBS) Devices Market by Application
11.4.5.3 China Deep Brain Stimulation (DBS) Devices Market End-Use
11.4.6 India
11.4.6.1 India Deep Brain Stimulation (DBS) Devices Market by Product
11.4.6.2 India Deep Brain Stimulation (DBS) Devices Market by Application
11.4.6.3 India Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.7 Japan
11.4.7.1 Japan Deep Brain Stimulation (DBS) Devices Market by Product
11.4.7.2 Japan Deep Brain Stimulation (DBS) Devices Market by Application
11.4.7.3 Japan Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.8 South Korea
11.4.8.1 South Korea Deep Brain Stimulation (DBS) Devices Market by Product
11.4.8.2 South Korea Deep Brain Stimulation (DBS) Devices Market by Application
11.4.8.3 South Korea Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.9 Vietnam
11.4.9.1 Vietnam Deep Brain Stimulation (DBS) Devices Market by Product
11.4.9.2 Vietnam Deep Brain Stimulation (DBS) Devices Market by Application
11.4.9.3 Vietnam Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.10 Singapore
11.4.10.1 Singapore Deep Brain Stimulation (DBS) Devices Market by Product
11.4.10.2 Singapore Deep Brain Stimulation (DBS) Devices Market by Application
11.4.10.3 Singapore Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.11 Australia
11.4.11.1 Australia Deep Brain Stimulation (DBS) Devices Market by Product
11.4.11.2 Australia Deep Brain Stimulation (DBS) Devices Market by Application
11.4.11.3 Australia Deep Brain Stimulation (DBS) Devices Market by End-Use
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by Product
11.4.12.2 Rest of Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by Application
11.4.12.3 Rest of Asia-Pacific Deep Brain Stimulation (DBS) Devices Market by End-Use Channel
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Deep Brain Stimulation (DBS) Devices Market by country
11.5.1.2 Middle East Deep Brain Stimulation (DBS) Devices Market by Product
11.5.1.3 Middle East Deep Brain Stimulation (DBS) Devices Market by Application
11.5.1.4 Middle East Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.1.5 UAE
11.5.1.5.1 UAE Deep Brain Stimulation (DBS) Devices Market by Product
11.5.1.5.2 UAE Deep Brain Stimulation (DBS) Devices Market by Application
11.5.1.5.3 UAE Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.1.6 Egypt
11.5.1.6.1 Egypt Deep Brain Stimulation (DBS) Devices Market by Product
11.5.1.6.2 Egypt Deep Brain Stimulation (DBS) Devices Market by Application
11.5.1.6.3 Egypt Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Deep Brain Stimulation (DBS) Devices Market by Product
11.5.1.7.2 Saudi Arabia Deep Brain Stimulation (DBS) Devices Market by Application
11.5.1.7.3 Saudi Arabia Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.1.8 Qatar
11.5.1.8.1 Qatar Deep Brain Stimulation (DBS) Devices Market by Product
11.5.1.8.2 Qatar Deep Brain Stimulation (DBS) Devices Market by Application
11.5.1.8.3 Qatar Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Deep Brain Stimulation (DBS) Devices Market by Product
11.5.1.9.2 Rest of Middle East Deep Brain Stimulation (DBS) Devices Market by Application
11.5.1.9.3 Rest of Middle East Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.2 Africa
11.5.2.1 Africa Deep Brain Stimulation (DBS) Devices Market by country
11.5.2.2 Africa Deep Brain Stimulation (DBS) Devices Market by Product
11.5.2.3 Africa Deep Brain Stimulation (DBS) Devices Market by Application
11.5.2.4 Africa Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Deep Brain Stimulation (DBS) Devices Market by Product
11.5.2.5.2 Nigeria Deep Brain Stimulation (DBS) Devices Market by Application
11.5.2.5.3 Nigeria Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.2.6 South Africa
11.5.2.6.1 South Africa Deep Brain Stimulation (DBS) Devices Market by Product
11.5.2.6.2 South Africa Deep Brain Stimulation (DBS) Devices Market by Application
11.5.2.6.3 South Africa Deep Brain Stimulation (DBS) Devices Market by End-Use
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Deep Brain Stimulation (DBS) Devices Market by Product
11.5.2.7.2 Rest of Africa Deep Brain Stimulation (DBS) Devices Market by Application
11.5.2.7.3 Rest of Africa Deep Brain Stimulation (DBS) Devices Market by End-Use Channel
11.6 Latin America
11.6.1 Latin America Deep Brain Stimulation (DBS) Devices Market by country
11.6.2 Latin America Deep Brain Stimulation (DBS) Devices Market by Product
11.6.3 Latin America Deep Brain Stimulation (DBS) Devices Market by Application
11.6.4 Latin America Deep Brain Stimulation (DBS) Devices Market by End-Use
11.6.5 Brazil
11.6.5.1 Brazil America Deep Brain Stimulation (DBS) Devices Market by Product
11.6.5.2 Brazil America Deep Brain Stimulation (DBS) Devices Market by Application
11.6.5.3 Brazil America Deep Brain Stimulation (DBS) Devices Market by End-Use Channel
11.6.6 Argentina
11.6.6.1 Argentina America Deep Brain Stimulation (DBS) Devices Market by Product
11.6.6.2 Argentina America Deep Brain Stimulation (DBS) Devices Market by Application
11.6.6.3 Argentina America Deep Brain Stimulation (DBS) Devices Market by End-Use
11.6.7 Colombia
11.6.7.1 Colombia America Deep Brain Stimulation (DBS) Devices Market by Product
11.6.7.2 Colombia America Deep Brain Stimulation (DBS) Devices Market by Application
11.6.7.3 Colombia America Deep Brain Stimulation (DBS) Devices Market by End-Use Channel
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Deep Brain Stimulation (DBS) Devices Market by Product
11.6.8.2 Rest of Latin America Deep Brain Stimulation (DBS) Devices Market by Application
11.6.8.3 Rest of Latin America Deep Brain Stimulation (DBS) Devices Market by End-Use
12 Company profile
12.1 Abbott.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Drug Class/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Medtronic
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Drug Class/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Boston Scientific Corporation
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Drug Class/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Aleva Neurotherapeutics S.A.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Drug Class/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Nexstim
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Drug Class/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 LivaNova PLC
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Drug Class/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Neuropace Inc.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Drug Class/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Functional Neuromodulation Ltd.
12.8.2 Financials
12.8.3 Drug Class/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Aleva Neurotherapeutics SA.
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Drug Class/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Beijing PINS Medical Co., Ltd
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Drug Class/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Surgical Retractors Market Size was valued at USD 2.03 billion in 2023, and is expected to reach USD 3.54 billion by 2031, and grow at a CAGR of 6.8% over the forecast period 2024-2031.
The Pharmacy Benefit Management Market size was estimated at USD 553.49 billion in 2023 and is expected to reach USD 882.86 billion by 2031 at a CAGR of 6.01% during the forecast period of 2024-2031.
The Operating Room Management Market Size was valued at USD 2.89 billion in 2022, and is expected to reach USD 6.92 billion by 2030 and grow at a CAGR of 11.5% over the forecast period 2023-2030.
The Feminine Hygiene Products Market Size was valued at USD 24.1 billion in 2022 and is expected to reach USD 37.26 billion by 2030, and grow at a CAGR of 5.6% over the forecast period 2023-2030.
The Healthcare EDI Market Size was valued at USD 3.81 billion in 2022, and is expected to reach USD 7.53 billion by 2030, and grow at a CAGR of 8.9% over the forecast period 2023-2030.
The Healthcare Information Technology Market Size was valued at USD 229.43 billion in 2023, and is expected to reach USD 1827.12 billion by 2031 and grow at a CAGR of 29.61% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
